• (Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph₂PCH₂CH₂SPh-κ<em>P</em>,κ<em>S</em> Ligand
• A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma
• A Comprehensive Review and Insights into the New Entity of Differentiated High-Grade Thyroid Carcinoma
• A novel mutation in PTEN in anaplastic thyroid carcinoma: A case report
• A phase I/II trial of sapanisertib in advanced anaplastic and radioiodine refractory differentiated thyroid carcinoma
• A rapidly enlarging neck mass
• A zebrafish xenotransplant model of anaplastic thyroid cancer to study the tumor microenvironment and innate immune cell interactions in vivo
• Activating transcription factor 3 mediates apoptosis and cell cycle arrest in TP53-mutated anaplastic thyroid cancer cells
• Alginate/carboxymethyl chitosan core-shell microspheres co-loaded with docetaxel/doxorubicin reverse chemotherapy resistance in anaplastic thyroid carcinoma
• Alginate/Carboxymethyl Chitosan Core-Shell Microspheres Coloaded with Doxorubicin/Docetaxel Reverse Chemotherapy Resistance in Anaplastic Thyroid Carcinoma
• An overview of the contemporary diagnosis and management approaches for anaplastic thyroid carcinoma
• An Overview on Prevalence and Detection Approaches of BRAF V600E Mutation in Anaplastic Thyroid Carcinoma: A Systematic Review and Meta-Analysis
• Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma
• Anaplastic thyroid cancer cell-secreted TGFbeta1 plays a key role in inducing macrophage polarization of human monocytes
• Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocol
• Anaplastic thyroid cancer: Unveiling advances in diagnosis and management
• Anaplastic thyroid carcinoma transformation in a patient with advanced non-small cell lung cancer treated with PD-1 therapy: A case report
• Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro
• B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma
• C5AR1-induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer
• CD3/PD-L1 bispecific aptamer enhances immune cytotoxicity against PD-L1 positive anaplastic thyroid cancer cells
• Cervical lymph node metastasis as the first symptom of combined anaplastic thyroid carcinoma (squamous cell carcinoma) and follicular carcinoma: a case report
• Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms
• Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model
• Charged particle radiotherapy for thyroid cancer. A systematic review
• Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight Cases
• Combined radiation and chemotherapy versus monotherapy for anaplastic thyroid cancer: A SEER retrospective analysis
• Comprehensive genomic profiling from C-CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1
• Current status of anaplastic thyroid carcinoma
• Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity
• Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database
• Development of a novel dynamic nomogram for predicting overall survival in anaplastic thyroid cancer patients with distant metastasis: a population-based study based on the SEER database
• Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Various Pathological Types
• DICER1 Mutations Define the Landscape of Poorly Differentiated Thyroid Carcinoma in Children and Young Adults: Case Report and Literature Review
• Disrupting glycolysis and DNA repair in anaplastic thyroid cancer with nucleus-targeting platinum nanoclusters
• dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe
• Effectiveness of prognostic nutritional index in predicting overall survival and evaluating immunotherapy response in anaplastic thyroid carcinoma
• Efficacy and safety of BRAF/MEK inhibitors in BRAFV600E-mutated anaplastic thyroid cancer: a systematic review and meta-analysis
• Elevations of neutrophil-to-lymphocyte ratio and C-reactive protein over time as a precursor to anaplastic transformation of papillary thyroid carcinoma: a case report
• Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies
• Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
• Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks
• Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan
• Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells
• Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis
• Improved Survival of Advanced-Stage Anaplastic Thyroid Cancer With Systemic Therapy
• Incorporating Network Pharmacology and Experimental Validation to Identify Bioactive Compounds and Potential Mechanisms of Digitalis in Treating Anaplastic Thyroid Cancer
• Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement
• Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression
• Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5(th) edition WHO classification
• KLHL14 is a tumor suppressor downregulated in undifferentiated thyroid cancer
• Long Non-Coding RNAs as Determinants of Thyroid Cancer Phenotypes: Investigating Differential Gene Expression Patterns and Novel Biomarker Discovery
• Long-Term Survival of a Patient With Anaplastic Thyroid Carcinoma Treated With Hypofractionated Radiotherapy: A Case Report
• Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer
• Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma
• METTL3 regulates thyroid cancer differentiation and chemosensitivity by modulating PAX8
• Molecular diagnostics enable targeted therapies for anaplastic and poorly differentiated thyroid cancer
• Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification
• Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy
• Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience
• Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report
• New strategy for intraoperative phonosurgical management of recurrent laryngeal nerve infiltrated by thyroid carcinoma
• OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma
• Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling
• Papillary Thyroid Cancer Remodels the Genetic Information Processing Pathways
• Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition
• PD-L1 and B7-H3 are Effective Prognostic Factors and Potential Therapeutic Targets for High-Risk Thyroid Cancer
• PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma: A Multi-institutional Study
• Personalized Management of Malignant and Non-Malignant Ectopic Mediastinal Thyroid: A Proposed 10-Item Algorithm Approach
• Poorly differentiated thyroid cancer: Clinical, pathological, mutational, and outcome analysis
• Poorly Differentiated Thyroid Carcinoma in a 19-Year-Old Young Female Patient: A Case Report
• Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives
• Predictive value of hematologic parameters and clinicopathological features of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
• Primary Squamous Cell Carcinoma of the Thyroid Has a Molecular Genetic Profile Distinct From That of Anaplastic Thyroid Carcinoma: A Whole Exome Sequencing and Gene Expression Profiling Study
• Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies
• Promising Therapeutic Targets for Recurrent/Metastatic Anaplastic Thyroid Cancer
• Prosapogenin A induces GSDME-dependent pyroptosis of anaplastic thyroid cancer through vacuolar ATPase activation-mediated lysosomal over-acidification
• Rare Columnar Cell Variant of Papillary Thyroid Carcinoma with Cervical Spine Metastasis: A Case Report
• Rare Thyroid Diseases Mimicking or Concealing Primitive Thyroid Neoplasms: A Call for a "Check and Double-Check" Clinical Mindset
• Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer
• Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer
• Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line
• Research progress of immunotherapy against anaplastic thyroid cancer
• Selective anti-tumor activity of glutathione-responsive abasic site trapping agent in anaplastic thyroid carcinoma
• Severe hypereosinophilia as a paraneoplastic syndrome in a patient with differentiated thyroid cancer
• Synergistic effects of the combination of trametinib and alpelisib in anaplastic thyroid cancer with BRAF and PI3KCA co-mutations
• Synergy between isobavachalcone and doxorubicin suppressed the progression of anaplastic thyroid cancer through ferroptosis activation
• Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer
• The coexistence of papillary thyroid carcinoma, anaplastic thyroid carcinoma (squamous cell carcinoma subtype) and poorly differentiated thyroid carcinoma: a case report
• The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies
• The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy
• The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review
• The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates
• Thyroid carcinomas: the role of systemic therapies in internal medicine
• Treatment of Unresectable BRAF V600E, TERT-Mutated Differentiated Papillary Thyroid Cancer With Dabrafenib and Trametinib
• Trends in Mortality for Anaplastic Thyroid Cancer: Have We Made Progress?
• UBR1 promotes anaplastic thyroid carcinoma progression via stabilizing YAP through monoubiquitylation
• Uncommon molecular alterations in follicular-derived thyroid carcinoma: A single institution study
• WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm
• Wnt/beta-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma